Evidence map›Paper›PMID 38928223›Full record

ArticleInternational journal of molecular sciences2024

Methylation-Based Characterization of a New

Simon Burgermeister, Simona Stoykova, Fanny S Krebs, Vincent Zoete, Martial Mbefo, Kristof Egervari, Antoine Reinhard, Bettina Bisig, Ekkehard Hewer

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Simon BurgermeisterDepartment of Laboratory Medicine and Pathology, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.ORCID 0000-0002-1284-5284
Simona StoykovaDepartment of Laboratory Medicine and Pathology, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.
Fanny S KrebsComputer-Aided Molecular Engineering, Department of Oncology UNIL-CHUV, University of Lausanne, 1066 Epalinges, Switzerland.ORCID 0000-0002-6291-7936
Vincent ZoeteComputer-Aided Molecular Engineering, Department of Oncology UNIL-CHUV, University of Lausanne, 1066 Epalinges, Switzerland.ORCID 0000-0002-2336-6537
Martial MbefoDepartment of Laboratory Medicine and Pathology, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.
Kristof EgervariService of Clinical Pathology, Department of Diagnostics, Geneva University Hospitals, 1206 Geneva, Switzerland.
Antoine ReinhardDepartment of Otorhinolaryngology-Head and Neck Surgery, Lausanne University Hospital, 1011 Lausanne, Switzerland.ORCID 0000-0003-2420-9100
Bettina BisigDepartment of Laboratory Medicine and Pathology, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.ORCID 0000-0002-6840-375X
Ekkehard HewerDepartment of Laboratory Medicine and Pathology, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.ORCID 0000-0002-9128-0364

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mutations affecting codon 172 of the isocitrate dehydrogenase 2 (

Indexed as

CarcinomaDNA MethylationIsocitrate DehydrogenaseMaxillary Sinus NeoplasmsMutationAgedFemaleHumansMaleMiddle AgedIDH2 protein, humanIsocitrate DehydrogenaseIDH2 mutationmethylation analysismolecular modeling

Identifiers

PMID38928223
PMCPMC11204065

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.